132 related articles for article (PubMed ID: 23589095)
1. Cdc42 is involved in basal cell carcinoma carcinogenesis.
Tucci MG; Lucarini G; Zizzi A; Rocchetti R; Brancorsini D; Di Primio R; Ricotti F; Ricotti G
Arch Dermatol Res; 2013 Nov; 305(9):835-40. PubMed ID: 23589095
[TBL] [Abstract][Full Text] [Related]
2. N-cadherin expression level modulates integrin-mediated polarity and strongly impacts on the speed and directionality of glial cell migration.
Camand E; Peglion F; Osmani N; Sanson M; Etienne-Manneville S
J Cell Sci; 2012 Feb; 125(Pt 4):844-57. PubMed ID: 22275437
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin expression in basal cell carcinoma.
Pizarro A; Benito N; Navarro P; Palacios J; Cano A; Quintanilla M; Contreras F; Gamallo C
Br J Cancer; 1994 Jan; 69(1):157-62. PubMed ID: 8286199
[TBL] [Abstract][Full Text] [Related]
4. Differential patterns of placental and epithelial cadherin expression in basal cell carcinoma and in the epidermis overlying tumours.
Pizarro A; Gamallo C; Benito N; Palacios J; Quintanilla M; Cano A; Contreras F
Br J Cancer; 1995 Aug; 72(2):327-32. PubMed ID: 7640213
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin, alpha- & beta-catenin, and CD44V6 and the subcellular localization of E-cadherin and CD44V6 in normal epidermis and basal cell carcinoma.
Kooy AJ; Tank B; de Jong AA; Vuzevski VD; van der Kwast TH; van Joost T
Hum Pathol; 1999 Nov; 30(11):1328-35. PubMed ID: 10571513
[TBL] [Abstract][Full Text] [Related]
6. ILK expression in human basal cell carcinoma correlates with epithelial-mesenchymal transition markers and tumour invasion.
Papanikolaou S; Bravou V; Gyftopoulos K; Nakas D; Repanti M; Papadaki H
Histopathology; 2010 May; 56(6):799-809. PubMed ID: 20546345
[TBL] [Abstract][Full Text] [Related]
7. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
8. Roles of E- and P-cadherin in the human skin.
Furukawa F; Fujii K; Horiguchi Y; Matsuyoshi N; Fujita M; Toda K; Imamura S; Wakita H; Shirahama S; Takigawa M
Microsc Res Tech; 1997 Aug; 38(4):343-52. PubMed ID: 9297684
[TBL] [Abstract][Full Text] [Related]
9. Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin.
Bartoš V; Kullová M
Acta Medica (Hradec Kralove); 2017; 60(1):32-36. PubMed ID: 28591550
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization of the differentiation state of basal cell carcinomas with special interest for infiltrating relapsing tumors.
Barbaud A; Simon M; Parache RM; Serre G
Eur J Dermatol; 1998; 8(5):320-4. PubMed ID: 9683887
[TBL] [Abstract][Full Text] [Related]
11. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
12. Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma.
Tucci MG; Lucarini G; Brancorsini D; Zizzi A; Pugnaloni A; Giacchetti A; Ricotti G; Biagini G
Br J Dermatol; 2007 Dec; 157(6):1212-6. PubMed ID: 17970806
[TBL] [Abstract][Full Text] [Related]
13. Newly formed E-cadherin contacts do not activate Cdc42 or induce filopodia protrusion in human keratinocytes.
Erasmus J; Aresta S; Nola S; Caron E; Braga VM
Biol Cell; 2009 Sep; 102(1):13-24. PubMed ID: 19583567
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours.
Fuller LC; Allen MH; Montesu M; Barker JN; Macdonald DM
Br J Dermatol; 1996 Jan; 134(1):28-32. PubMed ID: 8745882
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cadherin junctions during mouse submandibular gland development.
Menko AS; Zhang L; Schiano F; Kreidberg JA; Kukuruzinska MA
Dev Dyn; 2002 Jul; 224(3):321-33. PubMed ID: 12112462
[TBL] [Abstract][Full Text] [Related]
16. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.
van Hengel J; D'Hooge P; Hooghe B; Wu X; Libbrecht L; De Vos R; Quondamatteo F; Klempt M; Brakebusch C; van Roy F
Gastroenterology; 2008 Mar; 134(3):781-92. PubMed ID: 18325391
[TBL] [Abstract][Full Text] [Related]
17. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
18. The stromal reaction in basal cell carcinomas. A prerequisite for tumour progression and treatment strategy.
Bertheim U; Hofer PA; Engström-Laurent A; Hellström S
Br J Plast Surg; 2004 Jul; 57(5):429-39. PubMed ID: 15191824
[TBL] [Abstract][Full Text] [Related]
19. Interactions among IQGAP1, Cdc42, and the cadherin/catenin protein complex regulate Sertoli-germ cell adherens junction dynamics in the testis.
Lui WY; Mruk DD; Cheng CY
J Cell Physiol; 2005 Jan; 202(1):49-66. PubMed ID: 15389538
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
